Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Recombinant antibodies encoded by IGHV1-69 react with pUL32, a phosphoprotein of cytomegalovirus and B-cell superantigen.
Steininger C, Widhopf GF 2nd, Ghia EM, Morello CS, Vanura K, Sanders R, Spector D, Guiney D, Jäger U, Kipps TJ.
Blood. 2012 Mar 8;119(10):2293-301. Epub 2012 Jan 10.
Related citations
Transplant tourism--a dangerous journey?
Polcari AJ, Hugen CM, Farooq AV, Holt DR, Hou SH, Milner JE.
Clin Transplant. 2011 Jul-Aug;25(4):633-7. doi: 10.1111/j.1399-0012.2010.01325.x. Epub 2010 Oct 11.
Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis.
Boivin G, Goyette N, Farhan M, Ives J, Elston R.
J Clin Virol. 2012 Mar;53(3):208-13. Epub 2012 Jan 10.
General blockade of human cytomegalovirus immediate-early mRNA expression in the S/G2 phase by a nuclear, Daxx- and PML-independent mechanism.
Zydek M, Uecker R, Tavalai N, Stamminger T, Hagemeier C, Wiebusch L.
J Gen Virol. 2011 Dec;92(Pt 12):2757-69. Epub 2011 Aug 10.
Preventative tools of the future: predicting the individual risk of cytomegalovirus infection after transplant.
Kotton CN.
Transplantation. 2012 Mar 15;93(5):467-8. No abstract available.
Analysis of the interactions of viral and cellular factors with human cytomegalovirus lytic origin of replication, oriLyt.
Kagele D, Rossetto CC, Tarrant MT, Pari GS.
Virology. 2012 Mar 15;424(2):106-14. Epub 2012 Jan 10.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on